22.626 articles found

GLYCOLIPIDS AS TREATMENT FOR DISEASE

DEFREES SHAWN.

· 2010-03-25

GLYCOLIPIDS AS TREATMENT FOR DISEASE

DEFREES SHAWN.

· 2010-03-25

Pharmacological Treatment of Parkinson's Disease

WOLF WILLIAM A, ISTRE ERIK D.

· 2010-03-24

When do levodopa motor fluctuations first appear in Parkinson's disease?

Stocchi F, Jenner P, Obeso JA.

Eur Neurol · 2010-03-24

DOI: 10.1159/000300647PMID: 20332641

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole.

Kohen I, Lester PE, Lam S.

Neuropsychiatr Dis Treat · 2010-03-24

DOI: 10.2147/ndt.s6411PMID: 20361061

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE

SCHENK DALE B, MASLIAH ELIEZER.

· 2010-03-23

Resveratrol as a therapeutic agent for neurodegenerative diseases.

Sun AY, Wang Q, Simonyi A, Sun GY.

Mol Neurobiol · 2010-03-21

DOI: 10.1007/s12035-010-8111-yPMID: 20306310

LEVODOPA DIMETHYL-SUBSTITUTED DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE

XIANG JIA-NING, ZHOU CINDY X, YAO FENMEI, NGUYEN MARK Q.

· 2010-03-18

PARKINSON'S DISEASE MODEL MOUSE, PROCESS FOR PRODUCING THE MOUSE, AND SCREENING METHOD AND EVALUATION METHOD FOR THERAPEUTIC AGENT FOR PARKINSON'S DISEASE EACH USING THE MOUSE

IWAI KAZUHIRO, HATTORI NOBUTAKA, SAKATA SHIN-ICHI.

· 2010-03-18

Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias.

Ouattara B, Hoyer D, Grégoire L, Morissette M, Gasparini F, Gomez-Mancilla B, Di Paolo T.

Neuroscience · 2010-03-18

DOI: 10.1016/j.neuroscience.2010.03.022PMID: 20303391

Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Fuxe K, Marcellino D, Borroto-Escuela DO, Guescini M, Fernández-Dueñas V, Tanganelli S, Rivera A, Ciruela F, Agnati LF.

CNS Neurosci Ther · 2010-03-16

DOI: 10.1111/j.1755-5949.2009.00126.xPMID: 20345970

Targeted exercise therapy for voice and swallow in persons with Parkinson's disease.

Russell JA, Ciucci MR, Connor NP, Schallert T.

Brain Res · 2010-03-15

DOI: 10.1016/j.brainres.2010.03.029PMID: 20233583